Clinical characteristics and pathogenetic mechanisms of development of cognitive disfucntion in chronic kidney disease patients
- Authors: Rogova I.V1, Fomin V.V1, Damulin I.V1, Minakova E.G1, Yu Seklivanova O.Y.1, Shashkova E.V1, Petleva Y.A1
-
Affiliations:
- Issue: No 4 (2013)
- Pages: 27-32
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/261813
- ID: 261813
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
I. V Rogova
V. V Fomin
I. V Damulin
E. G Minakova
O. Yu Yu Seklivanova
E. V Shashkova
Yu. A Petleva
References
- Raphael K.L., Wei G., Greene T. et al. Cognitive function and the risk of death in chronic kidney disease. Am. J. Nephrol. 2012; 35(1): 49-57.
- Дамулин И.В. Когнитивные нарушения при сосудистых заболеваниях головного мозга: некоторые аспекты диагностики и терапии. Фарматека. 2011; 19: 20-28.
- Leys D., Englund E., Erkinjuntti T. Vascular dementia. In: Evidence-based Dementia Practice. Ed. by N.Qizilbash et al. Oxford etc.: Blackwell Science, 2002.460-287.
- Etgen T., Chonchol M., Förstl H., et al. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol. 2012;35(5): 474-825.
- Collins A.J., Foley R.N., Herzog C. et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2011; 57: 1-526.
- Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте. Методическое пособие для врачей. М.: Медицина 2005: 27-31.
- Кутырина И.А. Ремоделирование сосудов при хронической почечной недостаточности. В: Мухин Н.А (ред). Нефрология. Национальное руководство. М.: «Гэотар-Медиа»; 2009: 608-616.
- Kurella Tamura M., Xie D., Yaffe K. et al. Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol. 2011; 6(2): 248-256.
- Yaffe K., Ackerson L., Kurella Tamura M. et. al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J. Am Geriatr. Soc. 2010; 58(2): 338-345.
- Khatri M., Nickolas T., Moon Y.P., Paik M.C. CKD Associates with Cognitive Decline. J. Am. Soc. Nephrol. 2009; 20(11): 2427-2432.
- Helmer C., Stengel B., Metzger M. et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology. 2011; 77(23): 2043-2051.
- Tamura M.K., Wadley V., Yaffe K. et al. Kidney function and cognitive impairment in US adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Kidney Dis. 2008; 52: 227-234.
- Kurella M., Yaffe K., Shlipak M.G., et al. Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis. 2005; 45: 66- 76.
- Seliger S.L., Siscovick D.S., Stehman-Breen C.O. et al. Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition study. J Am Soc Nephrol. 2004; 15: 1904-1911.
- Hailpern S.M., Melamed M.L., Cohen H.W. et al. Moderate Chronic Kidney Disease and CognitiveFunction in Adults 20 to 59 Years of Age: Third National Health and Nutrition Examination Survey (NHANES III). J. Am. Soc. Nephrol. 2007; 18: 2205-2213.
- Sarbjit V. Jassal, Roscoe J., LeBlanc D. et al. Differential impairment of psychomotor efficiency and processing speed in patients with chronic kidney disease. Int Urol Nephrol 2008; 40: 849-854.
- Elias M.F., Elias P.K., Seliger S.L. et al. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009; 24: 2446-2452.
- Vermeer S.E., Longstreth W.T. Jr, Koudstaal P.J. Silent brain infarcts: A systematic review. Lancet Neurol 2007; 6: 611-619.
- Seliger S.L., Longstreth W.T. Jr, Katz R. et al. Cystatin C and subclinical brain infarction. J. Am. Soc. Nephrol 2005; 16: 3721-3727.
- Debette S., Beiser A., DeCarli C. et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: The Framingham Offspring Study. Stroke 2010; 41: 600-606.
- Kim C.D., Lee H.J., Kim D.J. et. al. High prevalence of leukoaraiosis in cerebralmagnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis 2007; 50: 98-107.
- Longstreth W.T. Jr, Manolio T.A., Arnold A. et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-1282.
- Blacher J., Guérin A.P., Pannier B. et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999; 99: 2434-2439.
- Szeto C.C., Chow K.M., Woo K.S. et al. Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. Am Soc Nephrol. 2007; 18: 1966-1977.
- Rabkin S.W. Arterial stiffness: detection and consequences in cognitive impairment and dementia of the elderly. J Alzheimers Dis 2012; 32(3): 541-549.
- Sander K., Bickel H., Förstl H. et al. Carotid-intima media thickness is independently associated with cognitive decline. The INVADE study. Int J Geriatr Psychiatry 2010; 25(4): 389-394.
- Atti A.R., Palmer K., Volpato S. et al. Anaemia increases the risk of dementia in cognitively intact elderly. 2006 Feb; 27(2): 278-284.
- Rabie T., Marti H.H. Brain protection by erythropoietin: a manifold task. Physiology (Bethesda) 2008; 23: 263-274.
- Pickett J.L., Theberge D.C., Brown W.S. et al. Normalizing hematocrit in dialysis patients improves brain function. Am. J. Kidney Dis.1999; 33: 1122-1130.
- Brines M.L., Ghezzi P., Keenan S. et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl Acad. Sci. 2000; 97; 10526-10531.
- Pfeffer M.A., Burdmann E.A., Chen C.Y. et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N. Engl. J. Med. 2009; 361: 2019-2032.
- Drueke T.B., Locatelli F., Clyne N. et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N. Engl. J. Med. 2006; 355: 2071-2084.
- Prins N.D., Den Heijer T., Hofman A. et al.; Rotterdam Scan Study. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002; 59: 1375-1380.
- Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci. 2004; 226: 25-29.
- Massy Z.A. Importance of homocysteine, lipoprotein(a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. Nephrol Dial Transplant 2000; 15: 81-91.
- Seshadri S., Wolf P.A., Beiser A.S. et al. Association of plasma total homocysteine levels with subclinical brain injury: Cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 2008; 65: 642-649.
- Lipton S.A., Kim W.K., Choi Y.B. et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-Daspartate receptor. Proc Natl Acad Sci 1997; 94: 5923-5928.
- Kwok T., Lee J., Law C.B. et al. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Clin Nutr 2011; 30: 297-302.
- Brady C.B., Gaziano J.M., Cxypoliski R.A. et al. Homocystein lowering and cohnition in CKD: the Veteran Affairs homocystein study. Am J Kidney Dis 2009; 54: 440-449.
Supplementary files
![](/img/style/loading.gif)